Another essential result of the study was that the inhibitory anti‐tumour effects of propofol on colorectal cancer cells could be reversed by suppressing miR‐124‐3p.1 expression or the overexpression of AKT3. The gene discussed is AKT3; the disease is colorectal cancer.